Pathology AI. #1 Best in KLAS. Enterprise-grade intelligence for the decisions that matter most.

Joined October 2013
1,388 Photos and videos
Pinned Tweet
8 Oct 2025
Proscia is rewiring pathology for precision medicine. We’ve partnered with the world’s leading labs and biopharma companies, and are backed by $130M in investment to bring that mission to life.
2
7
1,614
Jun 11
The conversation around AI in medicine often focuses on the technology itself, but its value lies in how it empowers the people doing the work. In pathology, that means less administrative burden, better access to context, and more time for the expertise that matters most. Where does AI deliver the greatest everyday value for pathology teams? Let us know below.
2
58
Jun 10
Dr. Sajjad Malik made one bold call - go fully digital, all at once - and held the line while multiple teams and disciplines rallied behind it. "We're doing it for the right reasons: patient care and a better workflow." @HNL_LabMedicine was able to go fully digital within a single year. Meet more leaders who made the move: info.proscia.com/feats-of-st…
5
75
What's the best fuel for your next discovery? It might already be in your archives.
3
50
Pathology AI should elevate the experts making the decisions that matter most. Visit our team at Booth 21 during ECDP 2026 to see how Concentriq is helping pathologists and scientists to work fast, accurately, and at sale. We'd love to connect in Graz.
3
58
NextGen Pathology has selected Proscia! The Florida-based national group was an early mover to digital. Now, it’s adopting Concentriq to lay an AI foundation for its next phase of growth and position itself as a strategic partner for biopharma research. “Proscia’s bold vision continues to push what AI can do for pathology. We pride ourselves on bridging the old with the new, fostering trusted relationships while adopting the latest technologies. Concentriq will elevate our pathologists to focus on what they do best and grow the value that we deliver.” -Dr. Hadi Yaziji, Founder of NextGen Pathology. Read the full announcement: proscia.com/press-releases/n…
1
3
94
Call for nominations - Feats of Strength Every digital pathology transformation has a leader behind it - someone who took the risk, challenged the resistance, and made it happen. We want to hear about them. If you know a bold leader whose courage and vision deserve the spotlight in an upcoming Feats of Strength video, tell us their story. info.proscia.com/feats-of-st…
4
57
Becker's Hospital Review published new projections from HRSA on the physician specialties facing the greatest shortages by 2038. Pathology lands high on the list, with a 16% gap. It's widely understood that hiring alone won't close that gap. The other lever is capacity: helping pathologists do more, without adding more hours to their workday. Digital adoption and AI can elevate the experts, giving them their time back to focus on the work only they can do. beckershospitalreview.com/qu…
3
54
May 29
A recent study in Parkinson's research points to a promising new therapeutic target. Researchers found that a specifically modified form of alpha-synuclein actively contributes to the spread of disease pathology in the brain. To combat this, they developed a novel antibody, 6G6, designed to selectively target it.
1
4
69
May 29
When tested in preclinical models, the antibody significantly reduced the spread of pathology and protected critical dopaminergic neurons from degeneration.
1
3
44
May 29
Concentriq was used to manage the study's whole slide images, which the team then analyzed to quantify disease pathology across brain regions. Read the full paper here: biorxiv.org/content/10.64898…

3
47
May 28
As pathology continues to reshape the precision medicine value chain from drug discovery to diagnostics, this year’s #ASCO26 promises to be a good one. Our team is looking forward to being on the ground to learn, connect, and trade insights.
1
6
138
May 27
Dr. Amanda Hemmerich's advice for labs navigating digital pathology adoption? "Just go ahead and start. It'll give you something to grow on." As Global Director of Digital Pathology Innovation at IQVIA Laboratories, she challenged the status quo and unified five labs across four countries, coordinating teams spanning different time zones and stages of digital maturity to build end-to-end validation strategies. Explore the full Feats of Strength series to hear from the bold leaders transforming pathology: info.proscia.com/feats-of-st…
2
89
May 26
A great moment from HIMSS Europe. Stephan Fromme represented Proscia in Copenhagen as KLAS celebrated the 2026 Global Best in KLAS winners. Thank you to KLAS for continuing to elevate the voice of the customer across healthcare technology, and to HIMSS Europe for bringing the healthcare community together.
3
69
May 21
We polled our community on the biggest hurdles in digital pathology transformation. Check out the results below.
1
3
115
May 20
If you're evaluating digital pathology and run Epic Beaker as your LIS, how deeply does your platform actually integrate? We mapped a 90-day roadmap to Epic-native deployment, covering vendor evaluation, pilot validation, and go-live readiness.
1
4
88
May 20
Senior Integration Engineer Jacob Blaylock goes deeper on what interoperability really means in practice, and why it's the one of the biggest factors in deployment success. Read more: proscia.com/maximizing-your-…
3
53
May 18
Real tangible impact. That's how a top 20 pharma leader describes computational pathology on Concentriq.
2
68
May 15
According to @AACR, an estimated 18.6 million cancer survivors were living in the US as of 2025. Behind that number are patients, families, researchers, physicians, pathologists, nurses, and care teams who have turned decades of discovery into longer, fuller lives. National Cancer Research Month is a reminder that progress against cancer is built through years of science, care, persistence, and collaboration. And it continues because people across research and medicine keep pushing toward what every patient deserves.
6
74
May 14
Dr. Derrick Forchetti knew digital pathology was inevitable as soon as he first saw a scanner years ago. The hard part was convincing everyone else. He kept the conversation going with his quiet conviction, reminding his team that there was a better way to move slides around when frustrations would arise. Now, @SBMFdonors is digital. And the colleague who told Dr. Forchetti that he was never moving away from the microscope is still there. Watch the full conversation and meet the other leaders in our Feats of Strength series: na2.hubs.ly/H05v56Q0
1
4
116